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Abstract
Mitochondrial uncoupling protein-4 (UCP4) protects against Complex I deficiency as induced by 1-methyl-4-
phenylpyridinium (MPP
+), but how UCP4 affects mitochondrial function is unclear. Here we investigated how UCP4 affects
mitochondrial bioenergetics in SH-SY5Y cells. Cells stably overexpressing UCP4 exhibited higher oxygen consumption
(10.1%, p,0.01), with 20% greater proton leak than vector controls (p,0.01). Increased ATP supply was observed in UCP4-
overexpressing cells compared to controls (p,0.05). Although state 4 and state 3 respiration rates of UCP4-overexpressing
and control cells were similar, Complex II activity in UCP4-overexpressing cells was 30% higher (p,0.05), associated with
protein binding between UCP4 and Complex II, but not that of either Complex I or IV. Mitochondrial ADP consumption by
succinate-induced respiration was 26% higher in UCP4-overexpressing cells, with 20% higher ADP:O ratio (p,0.05). ADP/
ATP exchange rate was not altered by UCP4 overexpression, as shown by unchanged mitochondrial ADP uptake activity.
UCP4 overexpression retained normal mitochondrial morphology in situ, with similar mitochondrial membrane potential
compared to controls. Our findings elucidate how UCP4 overexpression increases ATP synthesis by specifically interacting
with Complex II. This highlights a unique role of UCP4 as a potential regulatory target to modulate mitochondrial Complex II
and ATP output in preserving existing neurons against energy crisis.
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Introduction
Mitochondrial oxidative phosphorylation generates cellular
energy in the form of ATP. It involves the flow of high-energy
electrons along the electron transport chain in mitochondria, from
Complex I and Complex II to Complex IV to molecular oxygen,
concomitantly creating a proton gradient across the inner
membrane [1]. Complex V (ATP synthase) utilizes this proton
gradient to drive ADP phosphorylation and generate ATP by
channeling the protons back to the matrix [2]. Some electrons are
diverted from this path to form reactive oxygen species (ROS)
[3,4]. Mitochondrial Complex I (NADH ubiquinone reductase)
deficiency, e.g. in Parkinson’s disease (PD), resulting in lower
available ATP levels and ROS damage, form a vicious cycle
causing further neurodegenerative damage [5,6]. Complex I
activity can be as low as 60% of normal activity in the substantia
nigra of PD brain [7]. Exploring means to compensate for
Complex I deficiency, presumably via Complex II, will be
beneficial to reduce such pathological damages.
Uncoupling proteins (UCPs) are mitochondrial solute carriers
that can regulate mitochondrial membrane potential (MMP) and
ROS levels [8–13], preferably via their uncoupling activity that
dissipates the proton gradient and reduces ROS generation during
oxidative phosphorylation, so called the ‘‘mild uncoupling
hypothesis’’ [14]. The physiological function and significance of
neuronal uncoupling proteins are still unclear. However, evidence
suggests that proton leak, as mainly mediated by UCPs, plays a
major role in uncoupling substrate oxidation and ATP synthesis
during oxidative phosphorylation [15,16]. UCP4 is a neuronal
specific UCP homologue, localized in mitochondrial inner
membrane [17,18]. Localization and functional studies suggest
that UCP4 may play a role in mitochondrial function [10,19–22],
however, there is a lack of studies concerning the role of UCP4 in
neuronal energy homeostasis, despite its distinctive distribution in
the brain neurons and astrocytes [23]. UCP4 suppresses apoptosis
and stimulates proliferation of adipocytes [24]. This protein can
also regulate calcium homeostasis [25]; knockdown of the protein
in primary hippocampal neurons resulted in calcium overload and
cell death [21]. Overexpressing UCP4 reduced MMP in non-
neuronal cells [17,24], but not in neuron-derived cells under
normal conditions [10]. UCP4 has been shown to be protective
against oxidative stress, and to promote both glycolysis and ATP
production in rat PC12 cells [21]. Recently, we found that UCP4
expression is positively regulated by the transcription factor of NF-
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promoter region, suggesting a role for UCP4 as a novel
downstream regulatory target in mitochondria responsive to the
canonical NF-kB pro-survival pathway [19]. Overexpressing
UCP4 in SH-SY5Y neuroblastoma cells resulted in lower
oxidative stress, but also unexpectedly higher cellular ATP levels
[10], which was in discrepancy with the effects of its homologues,
UCP2 and UCP5 [11,20,26–29]. Our findings suggest that UCP4
possesses distinctively different properties compared with other
UCP homologues. We hypothesized that the increased cellular
ATP levels seen as a result of increasing expression of UCP4 was
due to an increase in the efficiency of the respiratory complexes
and ATP synthesis in mitochondria.
In this study, we provided evidence of how UCP4 affects
mitochondrial bioenergetics. To gain this evidence we assayed the
activities of the respiratory complexes, oxygen consumption, and
the efficiency of ATP production. Our results indicated that UCP4
interacted with and activated Complex II activity, and conse-
quently ATP synthesis. We suggested that UCP4-mediated proton
leak may be an important factor leading to this consequence. Our
results have important implications, in which mitochondrial
Complex I is inhibited (e.g. in PD), regulatory effects of respiratory
Complex II by UCP4 may augment ATP synthesis and thus
minimize neuronal cell death due to energy deficiency.
Results
Overexpressing UCP4 increases total cellular ATP level
Stable overexpression of human UCP4 in SH-SY5Y cells
resulted in a significant increase in UCP4 protein (Fig. 1a). Total
cellular ATP level in whole cell lysates from UCP4-overexpressing
and vector control cells were determined by luciferase biolumi-
nescent assay. Under normal, untreated culture condition, UCP4-
overexpressing cells exhibited significantly higher total cellular
ATP level compared with vector controls (p,0.01), as observed
consistently in at least four independent clones of cells (n=4)
(Fig. 1b). The basal ATP levels in isolated mitochondria from cells
with and without UCP4 overexpression were 0.22760.01 and
0.2860.02 mmol ATP/mg mitochondria protein, respectively.
Neuroblastoma cells overexpressing UCP4 adopted faster
respiration with higher oxygen consumption
Endogenousrespiration ratesofUCP4-overexpressing and vector
cells were determined by measuring oxygen consumption using a
Clark-type polarographic oxygen electrode under normoxic culture
condition. Cells stably overexpressing UCP4 exhibited a consis-
tently higher rate (10.160.4%) of oxygen consumption (4.486
0.015 nmol O2/min/10
7 cell), compared with vector controls
(4.0560.029 nmol O2/min/10
7 cell) (p,0.01) (n=5) (Fig. 1c).
Thus UCP4-overexpressing cells have a high respiration rate in
accord with their higher total ATP level, as shown above.
UCP4 overexpressing mitochondria produced more ATP
via respiration mediated by Complex II, but not Complex
I
Having demonstrated that UCP4-overexpressing cells have
faster respiration with higher oxygen consumption, we investigated
the role of UCP4 in enhancing the efficiency of ATP synthesis.
Changes in ATP levels were determined in mitochondria isolated
from UCP4-overexpressing or vector control cells in either
Complex I or II-mediated respiration. Initial basal ATP levels in
mitochondria were determined immediately after isolation.
Addition of Complex I-substrates (glutamate & malate) and ADP
induced the activities of respiratory chain Complexes I, III, IV,
and V. There was no significant difference in total amount of ATP
produced by mitochondria with and without UCP4 overexpres-
sion via Complex I-mediated respiration (Vector: 11.42961.49 vs.
UCP4: 11.24760.107 nmol ATP/mg mitochondria/nmol O2)
(n=3) (Fig. 2b). Succinate (Complex II substrate) induced activities
of Complexes II, III, IV, and V. Rotenone was included to inhibit
Figure 1. Bioenergetic characterization of SH-SY5Y cells stably
overexpressing UCP4. (a) Human UCP4 protein expression level was
significantly higher in UCP4-overexpressing cells than vector controls.
(b) Total intracellular ATP level in UCP4-overexpressing cells was higher
than vector control cells, as determined by luciferase bioluminescent
assay in total cell lysates. (c) Rate of respiration in vector control and
UCP4-overexpressing cells. Under normal culture condition, oxygen
consumption rate of UCP4-overexpressing cells was higher than vector
controls. Results are expressed as mean 6 SEM based on at least three
independent trials. ** represents statistical significance at p,0.01,
* represents p,0.05, compared to the vector control cells.
doi:10.1371/journal.pone.0032810.g001
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respiration was induced. The specificity of Complex II respiration
was indicated by the lack of response in oxygen consumption
shown in the resultant oxygraph when Complex I substrates
(glutamate & malate) and ADP were added (Fig. 2a). In contrast to
activation of Complex I, the amount of ATP produced in UCP4-
overexpressing mitochondria via Complex II was 67619% higher
than that in control mitochondria (Vector: 6.68461.01 vs. UCP4:
11.56662.14 nmol ATP/mg mitochondria/nmol O2;p ,0.01)
(n=5) (Fig. 2b). These results demonstrated that mitochondria in
which UCP4 was overexpressed produced more ATP than vector
controls via Complex II, but not Complex I.
UCP4 overexpression increases proton leak in isolated
mitochondria
The degree of proton leak affects ATP production in
mitochondria. Hence, the levels of proton leak were compared
between UCP4-overexpressing and vector cells in isolated
mitochondria. The ratio of oxygen consumption between
Complex V-insensitive respiration (by addition of oligomycin)
and the corresponding classical state 3 respiration was determined.
Mitochondria from UCP4-overexpressing cells had a significantly
higher level (20%) of proton leak (UCP4: 0.40560.019 vs. Vector:
0.33660.012; p,0.01) (n=3) (Fig. 3a–b) compared with that seen
in vector controls, confirming the fact that UCP4 functions as an
uncoupling protein. Because mitochondrial structural and func-
tional integrity may be affected during the isolation process
resulting in abnormal changes in oxygen consumption, the
integrity of the outer mitochondrial membrane was determined
in isolated mitochondria after stimulation with exogenous
cytochrome c. There were no changes in oxygen consumption in
all isolated mitochondria samples from UCP4-overexpressing or
vector cells after adding cytochrome c, indicating that the isolated
mitochondria were intact and functional (Fig. 3c).
UCP4 overexpressing mitochondria showed higher
ADP:O ratio in Complex II-sensitive respiration, but not
Complex I
Having observed higher cellular ATP levels in UCP4-overex-
pressing cells associated with increased oxygen consumption, we
compared the efficiency of ATP synthesis in mitochondria isolated
from both UCP4-overexpressing and control cells by measuring
their classical state 4 and state 3 respiratory rates and the
ADP:oxygen (ADP:O) ratio using a polarographic oxygen
electrode. The ADP:O ratio was obtained from the number of
moles of ATP generated per atom of oxygen consumed in the
presence of either Complex I- or Complex II-specific substrates. A
substrate mix of glutamate & malate was used to induce Complex
I-mediated respiration. Similarly, succinate was used to induce
Complex II-mediated respiration. Both classical state 4 and state 3
respiration rates in UCP4-overexpressing mitochondria were not
significantly different from those in vector cells, although they
seemed slightly lower than control cells (Table 1) (Fig. 4a, c).
Interestingly, ADP:O ratio associated with Complex II activity
with succinate (Complex II-specific substrate) was 20% higher in
UCP4-overexpressing mitochondria (Vector: 1.46860.0494 vs.
UCP4: 1.83060.0986; p,0.05) (n=5) (Fig. 4d), indicating a
higher efficiency in producing ATP via Complex II. Under this
condition, the ADP consumption of mitochondrial from UCP4-
overexpressing cells was significantly higher than those from vector
control cells (Vector: 64.266.5 vs. UCP4: 81.068.4 nmole ADP/
min/mg mitochondria protein; p,0.05) (n=4) (Fig. 4e). However,
the ADP:O ratios of both cell types for Complex I substrate
(glutamate & malate) -mediated respiration (Vector: 2.40460.108
vs. UCP4: 2.36060.149) were similar (n=5) (Fig. 4b). The
respiratory control ratios (RCR), frequently used as an index of
coupling for diagnosis of mitochondrial defects, between UCP4-
overexpressing and control mitochondria induced by either
Complex I- or II-specific substrates were similarly ranged within
2.5–3.0 (data not shown), being consistent with previous literatures
showing functional SH-SY5Y mitochondria [30–32].
UCP4 overexpression increased respiratory Complex II
activity, but not Complex I and IV
After observing an increase in ATP level and higher ADP:O
ratio under Complex II-mediated respiration in UCP4-overex-
Figure 2. Complex II-specific oxygen consumption and ATP
production of isolated mitochondria from UCP4-overexpress-
ing and vector control cells. (a) Oxygraph showing specificity of
Complex II-mediated respiration in isolated mitochondria induced by
succinate. Addition of rotenone (10 mM) completely blocked Complex I
activity, because addition of Complex I substrates (glutamate & malate)
and ADP did not induce oxygen consumption. Subsequently, addition
of Complex II substrate, succinate, induced oxygen consumption by
state 3 respiration. (b) Amount of ATP produced in isolated
mitochondria from vector and UCP4-overexpressing cells utilizing either
Complex I or Complex II substrates. UCP4 overexpression facilitates ATP
production using Complex II substrate (succinate). There was no
difference in amount of ATP produced when using Complex I substrate
(glutamate/malate). Basal value of ATP produced in vector control:
glutamate/malate (Complex I)=11.42 nmol ATP/mg mitochondria pro-
tein/nmol O2; succinate (Complex II): 6.68 nmol ATP/mg mitochondria
protein/nmol O2. Results are expressed as mean 6 SEM based on at least
four independent trials. ** represents statistical significance at p,0.01,
compared to the vector control cells. NS: not significant.
doi:10.1371/journal.pone.0032810.g002
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activities of individual respiratory complexes extracted from whole
cell lysates by spectrophotometric enzyme assay. The enzymatic
activity of Complex II in UCP4-overexpressing cells in normal
culture was significantly higher (30%), as compared with that of
vector controls (p,0.05) (n=3), as determined by the rate of
reduction of the artificial substrate, decylubiquinone (DB), in the
presence of the Complex I inhibitor, rotenone (Fig. 5b). This
increase in activity was not associated with significant changes in
the protein level of Complex II, as shown by similar levels of the
Complex II Fp subunit in the two cell types (Fig. 5c).
In contrast to the effects on Complex II, UCP4 overexpression
did not alter Complex I activity as shown by similar levels of
NADH oxidation rate in the two types of cells (Fig. 5a). Complex I
expression was also unchanged in both UCP4-overexpressing and
vector cells, as shown by similar levels of NDUFS4 (a Complex I
subunit) expression (Fig. 5c). UCP4 overexpression also did not
alter either Complex IV activity (n=3) (Fig. 5d), or Complex IV
subunit II protein expression (Fig. 5c). These results showed that
UCP4 overexpression specifically up-regulated Complex II
activity, but not those of Complex I and IV.
UCP4 protein interacts and is co-localized with Complex
II in mitochondria
To elucidate protein interaction between UCP4 and Complex
II, we performed co-localization study by immunocytochemistry,
and co-immunoprecipitation of UCP4 and a 70 kDa Complex II
subunit, Fp, using mitochondrial lysate extracted from UCP4-
overexpressing cells under native condition. UCP4 protein was co-
localized with Complex II as shown by double staining of
antibodies against UCP4 and Complex II subunit, Fp, under
confocal microscopy (Fig. 6a). For co-immunoprecipitation, in the
pull-down lysate using monoclonal antibody against Complex II
subunit, Fp, we detected the presence of UCP4-FLAG at 34 kDa
(Fig. 6b). Simultaneously, we detected the presence of Complex II
subunit, Fp, at 70 kDa in the resultant pull-down lysate using
FLAG antibody (Fig. 6b). These results indicate physical binding
between UCP4 and Complex II protein moiety.
Overexpression of UCP4 in mitochondria does not affect
ANT activity and expression of endogenous UCP5
We observed increased intracellular ATP level in UCP4-
overexpressing cells. Therefore, we investigated to see if the rate
of ATP export from mitochondria was affected by UCP4
overexpression. We explored changes in ADP/ATP exchange
activity, the expression of adenine nucleotide translocase (ANT),
and the steady-state mRNA level of the neuronal UCP homologue
(UCP5). These latter two particularly may affect MMP and ATP
level, and thus may confound our results. The rate of ADP/ATP
exchange was not significantly affected after UCP4 overexpression
as demonstrated by similar level of radioactive ADP uptake via
ANT (Fig. 7a). Level of ANT expression in UCP4-overexpressing
cells was also similar, as compared with that of the vector control
cells (Fig. 7a). UCP4 overexpression did not alter UCP5 mRNA
levels compared to the level in vector controls cells (n=3) (Fig. 7c),
Figure 3. Level of proton leak and integrity of isolated
mitochondria from UCP4-overexpressing and vector control
cells. (a) Oxygraphs showing changes in dissolved oxygen in isolated
mitochondria suspension from these cells under substrates-induced
respiration. Maximum rate of oxygen consumption was recorded for
2 min after addition of substrates containing 5 mM glutamate & malate,
5 mM succinate, and 0.5 mM ADP. ATP synthase inhibitor, oligomycin
(2.5 mg/ml) was then added to block ATP synthesis by Complex V. The
rate of oxygen consumption with oligomycin was recorded for an
additional 2 min, indicating Complex V-insensitive proton leak.
Numbers in brackets represent the rate of oxygen consumption in
mmol O2/min/mg mitochondrial protein. (b) The level of proton leak was
defined as the ratio of the rate of oxygen consumption in the presence
of oligomycin to the rate of substrates-stimulated oxygen consumption
(state 3 respiration). Results are expressed as mean ratios 6 SEM based
on at least three independent trials. ** represents statistical significance
at p,0.01, compared to the vector control. (c) Representative
oxygraphs reflecting integrity of the outer mitochondrial membrane
of isolated mitochondria isolated from both vector control and UCP4-
overexpressing cells. Exogenous cytochrome c (Cyt c) did not further
increase mitochondrial oxygen consumption. Intact and functional
mitochondria were demonstrated by state 3 respiration as stimulated
by addition of substrates (glutamate/malate/succinate) and ADP.
doi:10.1371/journal.pone.0032810.g003
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minimal.
Mitochondrial membrane potential (MMP) remained
unchanged in UCP4-overexpressing neuroblastoma cells
The relative MMP in cells overexpressing UCP4 was compared
with vector control cells by ratiometric measurement of intensity
from red and green after staining with JC-1. Stable overexpression
of UCP4 did not significantly alter the MMP under normal culture
condition, compared with vector control cells (Fig. 7b).
UCP4 overexpression does not affect mitochondria mass,
distribution, and morphology
Under transmission electron microscopy (TEM), mitochondria
from UCP4-overexpressing cells retained normal morphology in
Table 1. Classical state 4 and state 3 respiration rate in UCP4-overexpressing and control mitochondria.
Type of isolated
mitochondria
Complex I-mediated respiration (glutamate & malate)
(nmol O2/min/mg mito. protein)
Complex II-mediated respiration (succinate)
(nmol O2/min/mg mito. protein)
state 4 state 3 state 4 state 3
Vector control 0.00605860.00052 0.0162260.00131 0.0105460.000251 0.0201760.000601
UCP4 overexpression 0.0050060.000589 0.0138060.00124 0.00938660.000897 0.0171760.00182
doi:10.1371/journal.pone.0032810.t001
Figure 4. Mitochondrial oxygen consumption and ADP:oxygen
(ADP:O) ratio of isolated mitochondria from vector control and
UCP4-overexpressing cells. ADP-stimulated (state 3) and resting
(state 4) respiration rates are shown for mitochondria maintained in
normoxia at 25uC utilizing either (a–b) Complex I or (c–d) Complex II
substrates (i.e. glutamate & malate or succinate, respectively). UCP4-
overexpressing mitochondria demonstrated similar ADP:O ratio utilizing
(b) Complex I substrates, but was significantly higher when utilizing (d)
Complex II substrates, as compared to vector control mitochondria.
Results are expressed as mean 6 SEM based on at least six independent
measurements. * represents statistical significance at p,0.05, com-
pared to the vector control. NS: not significant.
doi:10.1371/journal.pone.0032810.g004
Figure 5. Mitochondrial Complex I, II and IV activity and
expression levels in vector control and UCP4-overexpressing
cells. Enzymatic activities of Complex I and II were measured in total
cell lysates using spectrophotometric enzyme assay as described in
Materials and Methods. (a)(i–ii) Complex I activity and (c) Complex I
subunit, NADH dehydrogenase (ubiquinone) Fe-S protein 4 (NDUFS4)
expression levels were similar in both vector control and UCP4-
overexpressing cells. (b)(i–ii) Complex II in sample lysates was
reactivated in 10 min pre-incubation period before assay. Complex II
activity was significantly higher in UCP4-overexpressing cells, but not (c)
the Complex-II Fp subunit expression level. (d) Complex IV activity and
(c) Complex IV subunit II expression levels were similar in both control
and UCP4-overexpressing cells. The expression level of mitochondria
marker, CoxIV, reflecting mitochondrial mass, was also similar between
UCP4-overexpressing and vector control cells. Results are expressed as
mean 6 SEM based on at least four independent trials. * represents
statistical significance at p,0.05, compared to the vector control cells.
NS: Not significant.
doi:10.1371/journal.pone.0032810.g005
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outer and inner membranes and tightly packed cristae, similar to
those in vector control cells (Fig. 7d). The subcellular distribution
of mitochondria in UCP4-overexpressing cells was also similar to
vector controls as shown under TEM (Fig. 7d). Moreover, UCP4
overexpression did not significantly alter total mitochondria mass
as determined by the ratio between the expression levels of
mitochondrial marker protein, CoxIV, and cytosolic house-
keeping b-actin (Fig. 5c).
Discussion
In this bioenergetic study of neuronal UCP4, we explored the
role of this mitochondrial protein in the regulation of the activity of
respiratory chain complexes and the efficiency of ATP synthesis in
SH-SY5Y neuroblastoma cells. In aerobic respiration, mitochon-
dria carry out oxidative phosphorylation to generate ATP from
nutrients and oxygen via a series of respiratory chain complexes.
Mitochondrial dysfunction impairs ATP production and forms a
‘‘vicious cycle’’ leading to further mitochondrial damage, which
causes excessive generation of reactive oxygen species (ROS), and
neuronal cell death [5]. Unlike other cell types, highly differen-
tiated neurons continuously suppress glycolysis to maintain their
Figure 6. Immunocytochemistry and co-immunoprecipitation
of UCP4 and mitochondrial Complex II in UCP4-overexpressing
SH-SY5Y cells. (a) UCP4 (red) and a 70 kDa Complex II subunit, Fp
(green), were co-localized in mitochondria. (b) Co-immunoprecipitation
and western blots of recombinant UCP4 protein and Complex II
subunit, Fp. Mitochondrial lysates from UCP4-overexpressing cells were
immunoadsorbed (IP) with either anti-FLAG or anti-70 kDa Fp, antibody
separately. The resultant antibody-protein pull-down lysates were
further adsorbed by Protein-G-sepharose beads. The adsorbed proteins
were cross-detected using anti-FLAG and anti-70 kDa Fp in western
blots. The pull-down lysate from anti-FLAG showed a band at 70 kDa
detected by anti-70 kDa Fp; and the pull-down lysate from anti-70 kDa
Fp showed a band at 34 kDa detected by anti-FLAG. IgG-heavy chain
and IgG-light chain were detected at ,55 kDa and ,25 kDa,
respectively. Dashed box showed non-specific bands from crude
mitochondrial lysate detected by anti-FLAG.
doi:10.1371/journal.pone.0032810.g006
Figure 7. Relative changes of ADP/ATP exchange activity, ADP
consumption and mitochondrial membrane potential in UCP4-
overexpressing cells. (a) ANT activity in vector control and UCP4-
overexpressing cells was determined using radioactive [
14C]ADP uptake
assay in isolated mitochondria. The ANT activities in both vector and
UCP4-overexpressing cells were similar. Protein expression of ANT was
also similar in both cell types. (b) ADP consumption in isolated
mitochondria from vector control and UCP4-overexpressing cells. UCP4-
overexpressing mitochondria consumed more ADP by succinate-
induced state 3 respiration. (c) Relative mitochondrial membrane
potential in vector control and UCP4-overexpressing cells were similar,
as determined by ratiometric (red/green ratio) measurement of JC-1
using spectrophotometry. (d) No corresponding change in UCP5
(neuronal UCP homologue of UCP4) mRNA expression in UCP4-
overexpressing cells compared to vector control as shown by
quantitative RT-PCR. Results are expressed as mean 6 SEM based on
three independent trials. ** represents statistical significance at p,0.01,
* represents p,0.05, compared to the vector control cells. NS: not
significant. (e) Morphology, intracellular distribution, and ultrastructure
of mitochondria in vector control and UCP4-overexpressing SH-SY5Y
cells were evaluated by transmission electron microscopy (TEM) at
magnification of 1:1650 and 1:8900. The mitochondrial morphology,
intracellular distribution and ultrastructure were similar in vector
control and UCP4-overexpressing cells. (Arrow: mitochondria).
doi:10.1371/journal.pone.0032810.g007
UCP4 Increases ATP Production via Complex II
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32810antioxidant status [33]. This makes neurons highly sensitive and
vulnerable to a shortage of energy supply when oxidative
phosphorylation is impaired. This is particularly important for
dopaminergic neurons in Parkinson’s disease (PD), in which
Complex I activity is significantly inhibited in the substantia nigra
neurons [34].
UCP4, which is exclusively expressed in mitochondria, seems to
be one of the major determinants in regulating mitochondria
activity to maintain neuronal energy homeostasis. In this study,
UCP4-overexpressing cells were shown to contain higher levels of
ATP compared with the level in vector control cells, which is in
accord with our previous findings [10]. We also demonstrate here
that overexpression of UCP4 resulted in a greater level of proton
leak from the inter-mitochondrial membrane space to the matrix,
which is in accord with what one would expect following the
increased expression of an uncoupling protein. Nevertheless, taken
in conjunction with one another, these two findings are somewhat
surprising, because one might anticipate that increasing proton
leak via high expression of an uncoupling protein would reduce
proton flow through Complex V and thus reduce ATP synthesis
[14,35]. Such a scenario occurs when another uncoupling protein,
UCP5, is overexpressed [11]. Here we show that the high
intracellular ATP content in UCP4-overexpressing cells was the
result of increased Complex II activity. This was accompanied by
higher oxygen consumption and a greater mitochondrial proton
leak, but with no effects on Complex I. Interestingly, this increase
in Complex II activity was not the result of increased expression of
Complex II proteins but due to increased efficiency of this
complex. The evidence for this is as follows: a) UCP4-
overexpressing cells had a higher rate of oxygen consumption
(Fig. 1c); b) UCP4 overexpression led to an enhanced rate of ATP
synthesis (Fig. 2b); c) higher Complex II activity was shown by the
in vitro enzymatic REDOX reaction (Fig. 5b); and d) the amount of
oxygen consumed per ATP produced was lower, as shown by the
increased ADP:O ratio when Complex I was inhibited by
rotenone and succinate was the only available substrate (Fig. 4d).
However, for Complex I we did not observe any significant
difference in the ADP:O ratio or any change in oxygen consumed
when Complex I was stimulated by glutamate & malate (Fig. 4a–
b). One may argue that ATP can also be produced from ADP
generated during state 4 respiration, but there were no significant
differences in state 4 and state 3 respiration between the two types of
mitochondria (Fig. 4a,c).
Although we observed higher ATP levels in total cell lysates of
UCP4-overexpressing cells compared with the levels in control
cells, we did not observe any significant difference in either the
activity or expression of ANT in isolated mitochondria from
UCP4-overexpressing cells compared with the levels in control
cells. One reason of the higher ATP level in UCP4-overexpress-
ing cells is possibly due to lower ATP consumption because the
demand to cope with stress responses is presumably lower in
UCP4-overexpressing cells. This postulation is reasonable
because there is growing evidence to show that UCP4 has a
regulatory role in the control of oxidative stress and ATP-
consuming apoptotic processes [10,24,36]. This overall effect of
higher ATP production in mitochondria and lower consumption
in other regions of the cell helps to explain why overexpressing
UCP4 is protective against ATP deficiency induced by the
mitochondrial toxin, MPP
+, as previously reported [10]. Fur-
thermore, we have excluded the possibility of increased
mitochondrial proliferation per cell in increasing total cellular
ATP because we did not observe any difference in levels of
CoxIV:actin expression ratio of UCP4-overexpressing cells
compared with that of control cells.
Overexpressing UCP4 increases ATP level sounds contradictory
to the classical ‘‘mild uncoupling hypothesis’’ in which UCPs
dissipate mitochondrial membrane potential via proton leak and
thereby decreasing ATP production [14]. This is true, but possibly
conditional. In order to prepare for cellular stresses, normal cells
should have reserved buffer of ATP production capacity to
increase ATP supply when needed, possibly via regulation by
UCPs. Partial uncoupling by UCPs causes proton leak from inter-
membrane space to the matrix but not necessarily depolarizing
mitochondrial membrane potential in live cells. An important
property of proton leak is that its level being highest only under
non-phosphorylating condition (i.e. classical state 4 respiration)
when ATP synthase (Complex V) is inhibited [37]. This extreme
condition will seldom happen in live cells (or the cells should have
died from energy deficiency), because normally proton leak will be
indirectly switched off to more thermodynamically favorable route
of proton entry via ATP synthase [37]. In fact, we did not observe
any significant change in mitochondrial membrane potential after
stably overexpressing UCP4. This is not surprising because
changes in MMP in live cells is highly dynamic over a short
period of time (usually within a second), and the presence of
different compensatory mechanisms in the mitochondrial mem-
brane, e.g. ANT activity [38,39], may confound any observations
and its interpretation. Any observable changes in MMP at one
particular time point could be an artefactual uncoupling [40].
Therefore, any change in MMP in a live cell model should be
interpreted as an overall effect from a cascade of biochemical
processes. MMP will steadily decrease only in artificial membra-
nous model (e.g. proteoliposomes) embedded with recombinant
uncoupling proteins [41], because it is a simple, unidirectional flow
of protons from one side of the membrane to the other without any
confounding compensatory proteins. This is only true when
protons, that are being pumped, are not being further ‘‘removed’’
or transported back to the other side of the membrane, e.g. in
artificial liposomes [42]. In a whole cell system, the uncoupling
function of UCPs is assumed to reduce ATP synthesis because of
partial dissipation of proton gradient, which bypasses ATP
synthase. However, this is valid only when it is assumed that
proton gradient is built to a far higher level than required or
reached the maximum capacity that ATP synthase can cope with
in ADP phosphorylation (i.e. maximum ATP production). Under
such hyperpolarized condition, oxidative phosphorylation also
produces ROS when single electrons are transferred to molecular
oxygen [43]. Only in such case, generation of harmful free radicals
can be suppressed by effective dissipation of such hyperpolarized
membrane potential by UCPs via proton leak. This is the reason
why uncoupling activity under such condition will suppress
oxidative stress, presumably by sacrificing ATP production.
However, cells under unstressed condition do not necessarily need
to maintain its ATP production state at maximum capacity, and
expression of UCPs may not necessarily means reduction of ATP
production. When compared with normal control cells, we
consistently observe a higher ATP level in cells which stably
overexpressing UCP4. Our results indicate that UCP4 expression
plays a key role in maintaining a buffer capacity for a cell to
further increase its ATP production ability via specific interaction
with Complex II, which strengthen the cell in energy supply
against cellular stresses.
We demonstrated a unique property of UCP4 that its
overexpression causes higher proton leak, and increases total
cellular ATP level. Such a unique property is not observed in
other UCP homologues, UCP2 and UCP5, in that they do not
increase ATP production [11,29,44]. Based on the specific
increase in Complex II activity by UCP4 overexpression, we
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bind to mitochondrial Complex II (Fig. 6b). We believe that such
interaction between UCP4 and Complex II facilitates the process
of ATP synthesis. In the respiratory chain reactions, Complex II
couples succinate oxidation to fumarate in the matrix with the
reduction of ubiquinone (UQ) in the membrane, via the four
protein subunits containing a bound flavin adenine dinucleotide
(FAD) cofactor and iron-sulfur clusters. Complex II does not
transport proton across the mitochondrial membrane, but
reduction of ubiquinone requires four protons in which two of
them are supplied by FADH2 carrying protons from the
oxidation of succinate to fumarate; whereas the other two
protons come from the proton pool in the matrix near Complex
II [45]. Provided that UCP4 uniquely interact with Complex II,
leakage of two protons via UCP4 may increase the regional
proton concentration in close proximity to Complex II, these two
additional protons carried through by UCP4 into the proton pool
in matrix will potentially facilitate the downstream reduction of
UQ, and consequently six additional protons will be pumped
back to the inter-membrane space via downstream chain
reactions in Complex III (four protons) and Complex IV (two
protons). As a result, the net effect will facilitate development of
proton gradient through downstream complexes and thereby
driving further oxidative phosphorylation and ATP production.
Such an explanation is consistent with our observation that
proton leak by overexpressing UCP4 can simultaneously increase
Complex II activity and ATP production. Although Complex I
also extracts protons from the proton pool during reduction of
UQ similar to Complex II, the activity and expression of
Complex I were not significantly affected by UCP4 overexpres-
sion. The reason why UCP4 selectively activated Complex II, but
not Complex I, depends on the specific protein-protein
interaction between UCP4 and Complex II. When considering
the fluid mosaic model of biological membrane (including
mitochondrial inner membrane), one possibility may be due to
specific steric interaction between these two partners (Fig. 8),
which brings UCP4 protein into close proximity to supply
protons to the UQ reduction site of Complex II where it hungers
for protons thermodynamically. Other possibilities may be that
UCP4 facilitates the dehydrogenation of succinate to fumarate to
increase supply of protons to Complex II. These possibilities need
to be further explored.
Examples of uncoupling proteins to regulate cellular ATP level
are common in different cell types. Previous reports showed that
UCP2 regulates cytosolic ATP/ADP ratio via control over glucose
metabolism in pancreatic b-cells [46]. Although the expression
level of UCP2 is relatively low when compared with UCP4 in
neuronal cells, our previous studies have indicated functional
similarities and potential compensation between UCP4 and
UCP2. We found that UCP2 expression was significantly induced
by mitochondrial toxin MPP
+, and overexpressing UCP4
completely abolished the induction of UCP2 in these neuroblas-
toma cells [20,47]. The role of UCP4 in neuronal energy
homeostasis is further supported by another UCP4 overexpression
neural cell model, which demonstrated increasing glucose uptake
and shifting of the mode of ATP production from mitochondrial
respiration to glycolysis, thereby maintaining cellular ATP levels
[21]. Although the extent of glycolysis contributing to the overall
ATP supply in neurons needs further exploration, it is not
surprising that UCP4 may play a role in mitochondria to regulate
ATP/ADP ratio indirectly via glycolytic pathways taken place in
the cytosol. Nevertheless, this also helps to explain why we
observed difference in change of ATP levels between whole cell
lysates and isolated mitochondria from UCP4-overexpressing cells
under Complex II-mediated oxidative phosphorylation. Further-
more, we demonstrated neuroprotective properties of UCP5
(neuronal homologue of UCP4) in attenuating ATP deficiency
against mitochondrial toxicity [11]. However, we did not detect
any significant change in UCP5 expression in our UCP4
overexpression model. Any potential interaction of UCP5 with
the respiratory complexes, and how it affects mitochondria
bioenergetic is unknown and requires further investigation.
In this bioenergetic study, we have demonstrated that
overexpressing UCP4 in neuroblastoma cells under normal culture
condition can increase mitochondrial ATP supply via direct
protein-protein interaction with Complex II to enhance its
REDOX activity. Despite that our findings in isolated mitochon-
dria were based on exposure to non-physiological condition, i.e. at
a higher oxygen and ADP concentration than the microenviron-
ment in vivo, it is interesting to note the effects of overexpressing
UCP4 on Complex II activity are specific, and that significant
increase in ATP production induced by UCP4 was not dependent
on any mitochondrial stresses. Also, one might argue for the
possibility that overexpressing protein in mitochondria might
Figure 8. Hypothetical model showing potential role of UCP4-mediated proton leak in facilitating Complex II-mediated oxidative
phosphorylation and ATP synthesis. UCP4 may span in close proximity to Complex II on the mitochondrial inner membrane to increase regional
proton concentration in the matrix, and facilitate subsequent reduction of ubiquinone (UQ) via heme-group to increase Complex II activity. Proton
leak via UCP4 may increase regional proton supply near Complex II, which boosts proton transport in the downstream respiratory Complex III and IV.
Net effect is a facilitation of high-energy electron flow along the respiratory chain to increase ATP synthesis.
doi:10.1371/journal.pone.0032810.g008
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mitochondrial function may confound one’s observations in
bioenergetic study. However, this is unlikely to happen because
the isolated mitochondria in our current model have demonstrated
increase in ATP production, and without undesirable oxygen
consumption as shown in exogenous stimulation of cytochrome c.
Also, the mitochondrial morphology in UCP4-overexpressing cells
is normal and comparable to control cells as shown in TEM. Our
data indicate that increasing expression of UCP4 in mitochondria
is sufficient to sustain a higher efficiency of respiratory chain
activities and ATP output under unstressed condition. To
understand the yet-unknown physiological role of UCP4, evidence
has emerged to show its significance [48,49]. Recent evidence has
demonstrated genetic linkages of UCP4 variants to the occurrence
of various neurological disorders, e.g. multiple sclerosis [50],
schizophrenia [51,52], and leukoaraiosis [53]. In experimental
animals, knocking out DJ-1 (a gene associated with an early-onset
form of PD) down-regulated UCP4 expression, where the authors
suggested that UCP4 (together with UCP5) may play a role to
compromise calcium-induced uncoupling and increase oxidation
of matrix proteins specifically in dopaminergic neurons [54]. We
have recently characterized the promoter region of human UCP4
gene and identified a potent NF-kB response element in this
region, where we found that TNF-a exposure in SH-SY5Y cells
induced UCP4 expression via binding with NF-kB transcription
factors [19]. Therefore, expression of neuronal UCP4, as a
potential downstream effector, implicates significant consequences
on neuronal function and determines the fate of neuronal survival
implicated in various neurodegenerative pathologies. Mitochon-
drial dysfunction is one of the final common pathways in variety of
neurological disorders, in which respiratory chain deficiency is
thought to play a crucial role in determining the fate of neurons,
e.g. Parkinson’s disease (PD) [55]. Mitochondrial Complex I
activity is reduced in substantia nigra of PD brains [56]. Current
treatment of PD does not address the underlying nigrostriatal
neurodegeneration. In preserving existing neurons, one such
strategy involves alleviating the harmful effects of downstream
pathogenic processes by targeting mitochondrial dysfunction in
PD. Our current study highlights a unique role of UCP4 in
regulating energy homeostasis, and may be a potential regulatory
target to specifically interact with mitochondrial Complex II to
increase ATP output in preserving existing neurons against energy
crisis, especially when Complex I is pathologically impaired.
Materials and Methods
Materials
Human SH-SY5Y neuroblastoma cells were obtained from
American Tissue Culture Collection (ATCC, CRL-2266). Dulbec-
co’sModifiedEagleMedium+GlutaMAX
TM-1NutrientMixture F-
12 (DMEM-F12), fetal bovine serum (FBS), penicillin-streptomycin,
Opti-MEM, Lipofectamine
TM 2000, pcDNA3.1(+)expression vec-
tor and Trizol
TM were from Invitrogen Life Technologies (CA,
USA); adenosine 59-diphosphate potassium salt (ADP) was from
Calbiochem (CA, USA). Taqman
TM EZ RT-PCR reagent kit,
probes, Primer Express
TM Software v.2.0, and StepOne Real-Time
PCR System and StepOne Software v2.0 were from Applied
Biosystems (CA, USA); Clark-type oxygen electrode in a water-
jacketed microcell (model MT200; 782 2-Channel Oxygen System;
Strathkelvin Instrments Ltd. Scotland); Bradford dye reagent and
PVDF membrane were from Bio-Rad (CA, USA); ATPlite
TM
luminescence ATP detection assay system from Perkin Elmer;
Complex IV Human Enzyme Activity Microplate Assay Kit was
from Mitosciences (OR, USA); Polyclonal anti-actin, Monoclonal
anti-NDUFS4 (1-E-4), polyclonal anti-ANT antibodies were from
Santa Cruz Biotechnology (MA, USA); anti-Complex II Fp subunit
and anti-Complex IV subunit II antibodies were from Mitosciences.
Polyclonal anti-CoxIV was from abcam (UK). Horseradish
peroxidase-conjugated secondary antibodies were from DAKO
(CA, USA); ECL-plus western blotting detection system and
Geneticin(G418)werefromGEHealthcare Ltd.(Buckinghamshire,
UK). All chemicals were from Sigma (MO, USA).
Cell culture and treatments
Human neuroblastoma SH-SY5Y cells were cultured in
DMEM-F12 supplemented with 10% FBS, 2 mM glutamine,
and 100 mg/ml penicillin-streptomycin (Invitrogen) at 37uCi na
humidified 5% CO2 atmosphere. UCP4 overexpressing SH-SY5Y
cells were selected by antibiotics G418 (200 mg/ml) after stably
transfected with a mammalian expression vector, pcDNA3.1(+),
overexpressing human UCP4 as previously described [10]. Cells
stably transfected with empty-vector were used as normal control.
Isolation of mitochondria
The mitochondria from SH-SY5Y cells were separated based on
differential centrifugations. Cells were harvested by centrifugation in
a mitochondrial isolation buffer containing 10 mM Tris-MOPS,
1 mM EGTA, 0.2 M sucrose, pH 7.4, and mechanically ruptured
using glass-telfon Potter Elvehjem homogenizer by 20–25 strokes.
The suspension was transferred to a fresh tube and centrifuged at
6506g for 10 min. at 4 uC to obtain the mitochondria-enriched
fraction. Isolated mitochondria were pelleted by further centrifuga-
tion at 70006g for 10 min. at 4 uC. The purified mitochondria were
obtained by an additional wash in isolation buffer and centrifugation
at 4 uC. The mitochondria were resuspended in mitochondrial
isolation buffer and kept on ice before experiments within two hours
afterextraction.Mitochondrialproteinconcentrationineachsample
was determined by the Bradford method and adjusted to 10 mg/ml.
Mitochondria morphology and integrity – Electron
microscopy and stimulation of cytochrome c-sensitive
respiration
The ultrastructure of mitochondria in vector control and UCP4-
overexpressing SH-SY5Y cells was assessed with transmission
electron microscopy (TEM). For whole cell electron microscopy,
cell suspension was fixed with 2.5% glutaraldehyde in phosphate
buffer,pH 7.4for1 hourat 4uC and postfixedwith1%OsO4 inthe
same buffer. The cell pellet was pre-warmed in a 50uC water bath
for 10 min. and suspended in 2% low-melting agar gel until
solidified. Afterwards, samples weredehydrated, embedded inEpon
resin and examined under a Philips EM208s transmission electron
microscope (EMU, University of Hong Kong). The integrity of
isolated mitochondria was also confirmed by tracing oxygen
consumption in response to exogenous cytochrome c using a
Clark-type oxygen electrode. Cytochrome c cannot penetrate an
intact mitochondrial outer membrane. Therefore, the absence of an
increase in oxygen consumption in isolated mitochondria in
response to exogenous cytochrome c is a convenient qualitative
confirmation of mitochondrial integrity [57].
Rate of respiration - oxygen consumption in whole cells
and isolated mitochondria
The rate of endogenous respiration was measured in either
UCP4-overexpressing or vector control cell suspensions. Briefly,
cells (1610
7) in the exponentially growing phase were trypsinized
and resuspended in fresh complete medium. Changes in oxygen
consumption were measured using a Clark-type oxygen electrode in
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consumption was recorded as nmol O2 consumed/min/610
7 cell.
Changes in oxygen consumption in isolated mitochondria from
either vector control or UCP4-overexpressing cells were measured
using the same oxygen electrode, magnetically stirred at 25uC. The
isolated mitochondria (100 mg) were injected into the microcell
using a Hamilton syringe at a final concentration of 1 mg/ml in
medium (100 ml) consisting of 125 mM KCl, 1 mM EGTA, 1 mM
KH2PO4, and 10 mM Tris–MOPS, pH 7.4, at 25uC. Classical state
4 and state 3 respiration rates were determined from the resultant
oxygraphs after subsequently injecting either Complex I or II-
substrates (i.e. 5 mM glutamate & malate or 5 mM succinate,
respectively) and 0.1 mM ADP. The rate of respiration is defined as
the rate of change of dissolved oxygen concentration in the
respiration assaybufferinnmol O2/mg mitochondrialprotein/min.
State 3 respiration was defined as the maximum rate of oxygen
consumption in the presence of substrates and ADP to undergo
ATP synthesis, whereas state 4 respiration was defined as the basal
oxygen consumption after ADP was depleted in the presence of
substrate. To measure the oxygen consumption due to Complex II
activity, 2 mM rotenone (Complex I inhibitor) was added into the
mitochondrial suspension to determine the Complex I-insensitive
oxygen consumption. The ADP:oxygen ratio (ADP:O) was
determined by an ADP pulse method with definite amount of
ADP (10nmoles) and Complex I and II-substrates [58]. Artificial
uncoupler, CCCP, was used to fully depolarize isolated mitochon-
dria in oxygen chamber after measurements to verify functional
specificity of intact mitochondria.
ADP consumption
The ADP consumption of isolated mitochondria from either
UCP4-overexpressing or vector control cells was calculated from
the oxygraph during succinate-induced state 3 respiration via
Complex II as described above. Briefly, 10nmole of ADP was
added into the oxygen chamber containing 100 mg isolated
mitochondria to initiate state 3 respiration. Complete consumption
of ADP was demonstrated by a distinct transition from state 3 to
state 4 respiration as shown by a decrease of oxygen consumption.
The level of ADP consumption was expressed as nmole ADP
consumed per min per milligram isolated mitochondria during
succinate-induced state 3 (maximum) respiration.
Proton leak - measurements of Complex V-insensitive
oxygen consumption
The levels of proton leak in isolated mitochondria from UCP4-
overexpressing and vector control cells were determined polar-
imetrically with a Clark-type oxygen electrode. Mitochondria were
resuspended at a concentration of 1 mg/ml in medium (100 ml)
consisting of 125 mM KCl, 1 mM EGTA, 1 mM KH2PO4, and
10 mM Tris–MOPS, pH 7.4, at 25uC. Maximum rate of oxygen
consumption was recorded for 2 min after addition of 5 mM
glutamate & malate, 5 mM succinate, and 0.5 mM ADP.
Oligomycin (2.5 mg/ml) was then added to inhibit ATP synthase
and block ATP production. The rate of oxygen consumption with
oligomycin was recorded for an additional 2 min. The level of
proton leak was defined as the ratio of the rate of oxygen
consumption in the presence of oligomycin to the rate of ADP-
stimulated oxygen consumption (classical state 3 respiration).
Adenine nucleotide translocase (ANT) ADP/ATP
exchange activity
The ADP/ATP exchange activity of ANT in mitochondria
isolated from UCP4-overexpressing and vector cells were
determined by inhibitor-stop method with slight modifications
[59]. Briefly, mitochondria were isolated according to the above
method, and suspended in ice-cold suspension buffer consisting of
125 mM KCl, 1 mM EGTA, and 10 mM Tris–MOPS, pH 7.4.
The mitochondria suspension (containing 100 mg mitochondria
protein in 500 ml buffer) was incubated with Complex V inhibitor,
oligomycin (2.5 mg/ml) for 15 min on ice to stop ATP synthesis
before experiments. After this pre-incubation step, 50 nmol of
[
14C]ADP were added to the mitochondrial suspension. The
reaction was carried out on ice for 40 sec and immediately stopped
by addition of 100 mM atractyloside. The mitochondria were
washed five times with fresh suspension buffer containing
atractyloside and collected by centrifugation. The resultant
mitochondrial pellet was dissolved in 0.1 M NaOH. The
radioactivity of [
14C]ADP in the NaOH solution was determined
using a scintillation counter.
Mitochondrial Complex I activity measurement
Mitochondrial Complex I activity was determined by spectro-
photometric enzyme assay as described with slight modifications
[60]. Briefly, culture medium of cells growing exponentially was
changed two hours before experiment. Cells were washed with
PBS and suspended in ice-cooled mitochondrial suspension buffer
containing 10 mM Tris-MOPS, 1 mM EGTA, 0.2 M sucrose,
pH 7.4, supplemented with protease inhibitor cocktail (Roche).
The cellular extracts containing mitochondrial membrane were
prepared by homogenization using glass-teflon homogenizer and
brief sonication. The resultant lysates were diluted to a
concentration of 5 mg/ml. Activity of Complex I was measured
by the colorimetric changes after oxidation of NADH at 340 nm
wavelength. The mitochondria-rich cellular fraction (200 mg) was
pre-incubated in 480 ml reaction buffer containing 35 mM
potassium phosphate buffer, pH 7.2, 1 mM EDTA, 1 mg/ml
BSA, 2.65 mM KCN, 5 mM MgCl2,2 mg/ml antimycin A,
2.5 mM decylubiquinone for 2 min at 37uC. After the pre-
incubation, 20 ml of 5 mM stock b-NADH was added to the
reaction mixture, and its absorbance at 340 nm was recorded
continuously for 5 min. at every 30 sec. intervals. Samples
incubated with 10 mM rotenone (Complex I inhibitor) were used
as negative control. The relative Complex I activity was defined as
the rate of change of absorbance per unit time of incubation after
subtracting the Complex I-insensitive absorbance in the presence
of rotenone.
Mitochondrial Complex II activity measurement
Mitochondrial Complex II activity was determined by standard
spectrophotometric enzyme assay as described with slight
modifications [60,61]. The mitochondria-rich cellular fractions
were prepared on ice as described above. Activity of Complex II
was measured by changes in absorbance at 600 nm after reduction
of artificial electron acceptor, 2,6-dichlorophenolindophenol
(DCPIP). The cellular fraction (200 mg) was pre-incubated in
480 ml reaction buffer containing 35 mM potassium phosphate
buffer, pH 7.2, 1 mM EDTA, 1 mg/ml BSA, 2.65 mM KCN,
50 mM DCPIP, 10 mM rotenone, 5 mM MgCl2, 0.2 mM ATP,
10 mM sodium succinate, 2 mg/ml antimycin A for 10 min at
37uC to allow lag period for activation of Complex II. After the
pre-incubation, 80 mM decylubiquinone was added to the reaction
mixture and its absorbance at 600 nm was recorded continuously
for 5 min. at every 30 sec. intervals. Samples incubated with
100 mM 3-nitropropionic acid (3-NP, Complex II inhibitor) were
used as negative control. The relative Complex II activity was
defined as the rate of change of absorbance per unit time of
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readings in the presence of 3-NP.
Mitochondrial Complex IV activity measurement
Mitochondrial Complex IV activity was measured using a
commercial Complex IV human enzyme activity assay kit
(Mitosciences) according to manufacturer’s procedure. Briefly,
cells were washed with PBS, and lysed by brief sonication on ice.
Complex IV in the resultant lysates was immune-captured within
the wells following overnight incubation at 4uC. After the
incubation, the substrate was added to each well to allow reaction
to proceed in which the reduced cytochrome c was oxidized. The
decrease in absorbance at 550 nm was recorded continuously for
2 hours. The relative Complex IV activity was defined as the rate
of change of absorbance per unit time of incubation.
Real-time quantitative RT-PCR and SDS-PAGE western
blotting
To determine the steady-state levels of UCP4 and UCP5
mRNAs, total RNA was isolated from UCP4-overexpressing, and
vector control cells by Trizol
TM reagent and treated with DNase-I
to remove genomic DNA. Real-time quantitative RT-PCR was
performed using the Taqman EZ RT-PCR reagent kit. The level
of b-actin was used to normalize loadings of total RNA. The
sequences of primers and probes for UCP4 and UCP5 have been
described previously [47].
To determine levels of a number of intracellular proteins,
cellular lysates were clarified by centrifugation and the total
protein concentrations were measured. SDS-PAGE western
blotting was performed using equal amounts of total cellular
protein lysate (25 mg), which were electrophoresed on 15% SDS-
polyacrylamide gels and then transferred overnight onto PVDF
membrane. The resulting blots were blocked with 5% non-fat
skimmed milk (Bio-Rad) and probed respectively with various
primary antibodies: anti-NDUFS4 (1-E-4) (1:1000), anti-Complex
II (1:10000), anti-Complex IV subunit II (1:1000), anti-CoxIV
(1:5000), anti-ANT (1:1000) and anti-actin (1:500) antibodies.
Resulting blots were incubated with horseradish peroxidase
(HRP)-conjugated secondary antibodies (1:5000) followed by
detection using ECL detection reagents. The resultant immuno-
blots were quantified by computerized scanning densitometry.
Mitochondrial membrane potential (MMP)
Relative MMP in vector control and UCP4-overexpressing cells
were compared by ratiometric measurement of an MMP-sensitive
fluorescent dye JC-1. Briefly, cells seeded in 96-well plate (10
5
cells/well) were stained in culture medium containing 10 mg/ml
JC-1 at 37uC in the dark for 15 min. After staining, the medium
was replaced by fresh medium. The fluorescent intensity of both
red (excitation: 485 nm; emission: 535 nm) and green (excitation:
546 nm; emission: 590 nm) of the stained cells were measured by
spectrophotometer (Infinite M200, TECAN). Relative MMP was
expressed as the average fluorescent signal of the dye (ratio of red
to green signals) from at least six individual wells.
Co-localization of UCP4 and Complex II -
immunocytochemistry
Co-localization of UCP4 and Complex II was demonstrated by
co-immunostaining of UCP4 and a 70 kDa Complex II subunit,
Fp, in UCP4-overexpressing cells. Briefly, cells were seeded at
50% confluency in chamber slides 24 hours before the immuno-
staining. Cells were fixed with 4% paraformaldehyde for 30 min at
room temperature, and incubated with the diluted goat polyclonal
anti-UCP4 primary antibody and mouse monoclonal anti-70 kDa
Fp at 4uC overnight, followed by co-incubation with Alexa Fluor
546-conjugated anti-mouse IgG (1:200) and Alexa Fluor 488-
conjugated anti-goat IgG (1:200) for 1 hour. Images were
visualized under confocal microscope (Carl Zeiss LSM 510).
Cellular nuclei were counterstained with DAPI.
Protein-protein interaction between UCP4 and Complex
II – co-immunoprecipitation
Mitochondria in UCP4-overexpressing cells were isolated as
described above. The resultant mitochondria-enriched pellet was
resuspended and lysed by a native lysis buffer under brief
sonication (Cell Signaling Ltd.). The mitochondrial lysate
(500 mg aliquot) was pre-absorbed by Protein-G-sepharose beads
for 30 min. at 4uC to capture non-specific proteins having direct
interaction with Protein-G. The pre-cleared supernatant was then
incubated with primary antibody against either FLAG or Complex
II subunit, Fp, at 4uC overnight with gentle agitation. The protein-
antibody complex was then incubated with fresh Protein-G-
sepharose beads for 1 hour at 4uC. The resulting antibody-
complexes suspension with sepharose beads were washed by Tris-
buffer, pH 7.2, supplemented with 0.01% Tween 20, then boiled
and denatured in SDS-containing sampling buffer, and run into
12% SDS-polyacrylamide gel. The resultant blots were blocked by
skimmed milk and probed with either anti-FLAG or anti-Complex
II subunit, Fp. Resulting blots were incubated with HRP-
conjugated secondary antibodies followed by detection using
ECL detection reagents.
Cellular ATP levels and the rate and efficiency of ATP
synthesis in isolated mitochondria
Both intracellular and mitochondrial ATP levels were assayed
using a commercial ATP assay kit (Perkin Elmer). For intracellular
ATP level, cells were washed with PBS and harvested under
normal culture condition. Total ATP was extracted in lysis buffer
containing: 100 mM potassium phosphate buffer (pH 7.8), 2 mM
EDTA, 1 mM DTT, and 1% Triton X-100. ATP level in each cell
lysate was determined by luciferase bioluminescent assay, in which
light emitted was measured by a luminometer.
To compare the efficiency and rate of ATP synthesis between
UCP4-overexpressing and vector control cells, fixed amount of
isolated mitochondria (100 mg) were incubated in respiratory
buffer containing 125 mM KCl, 1 mM EGTA, 1 mM KH2PO4,
1 mM ADP, and 10 mM Tris–MOPS, pH 7.4, with specific
substrates and inhibitors of the respiratory chain complexes.
Oxygen consumption was assayed using a Clark-type electrode in
microcell as described above. For Complex I-mediated ATP
synthesis, 5 mM glutamate and 1 mM malate were added to the
mitochondrial suspension to stimulate ATP production. For
Complex II-mediated ATP synthesis, 5 mM succinate was added
with a Complex I inhibitor, rotenone (2 mM). Mitochondrial
suspensions were incubated in a water-jacketed microcell,
magnetically stirred at 25uC for 4 min. After the incubation, a
specific ATP releasing buffer (Perkin Elmer) was immediately
added into the mitochondrial suspension to stop the respiratory
chain reactions and to lyse all mitochondria. ATP level was
determined in each mitochondrial lysate by luciferase biolumines-
cent assay. ATP concentrations were determined using a
calibration curve of serial ATP dilutions provided with the kit.
Basal intra-mitochondrial ATP levels in both UCP4-overexpress-
ing and control mitochondria were determined before incubation.
Total mitochondrial protein was used to normalize the amount of
ATP produced to allow comparison across groups without
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the oxygen chamber. Furthermore, changes in oxygen consump-
tion were recorded to monitor the process of substrates-induced
ATP synthesis to ensure state 3 respiration had taken place during
the incubation time period. The efficiency of ATP synthesis was
defined as (final ATP - initial ATP)/mg mitochondria protein/
oxygen atom consumed.
Statistical analyses
All experiments were repeated in at least four independent
treatments. Results were expressed as mean 6 S.E.M. Statistical
significance was assessed by one-way ANOVA followed by
Bonferroni’s post hoc analysis or by Student’s unpaired t-test.
Differences were considered significant if p,0.05.
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